Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine.
DL-2-amino-5-phosphonovaleric acid (AP-5), which blocks glutamatergic transmission at the NMDA-preferring receptor, was injected into the antero-dorsal striatum of rats. AP-5-induced behavioural changes were assessed i) using a stereotypy rating scale and ii) using an experimental chamber designed to quantify sniffing. In both behavioural situations it was shown that AP-5 (10 micrograms/0.5 microliter) induced continuous intensive sniffing similar to that induced by small doses of systemically administered amphetamine or apomorphine. However, oral stereotypies were not induced by AP-5. Systemically injected clozapine (5 and 10 mg/kg SC) as well as haloperidol (0.1 mg/kg IP) antagonized AP-5-induced sniffing. These results show that besides dopamine receptors, NMDA receptors are involved in the control of sniffing. In behavioural terms, the effect of glutamate mediated by the NMDA receptor in the striatum is opposite to that of dopamine.
D015763:2-Amino-5-phosphonovalerate; D000818:Animals; D003024:Clozapine / Q000494:pharmacology*; D003342:Corpus Striatum; D003913:Dextroamphetamine / Q000494:pharmacology; D003984:Dibenzazepines / Q000494:pharmacology*; D006120:Grooming / Q000187:drug effects; D006220:Haloperidol / Q000494:pharmacology*; D007267:Injections; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013239:Stereotyped Behavior / Q000187:drug effects*; D014633:Valine / Q000031:analogs & derivatives* / Q000494:pharmacology
D003984:Dibenzazepines; D015763:2-Amino-5-phosphonovalerate; D014633:Valine; D003024:Clozapine; D006220:Haloperidol; D003913:Dextroamphetamine